AI can now predict deadly heart arrhythmias up to two weeks in advance, potentially transforming cardiac care.
Artificial intelligence could play a key role in preventing many cases of sudden cardiac death, according to a new study published in the European Heart Journal. Researchers from Inserm, Paris Cité University, and the Paris public hospital group (AP-HP), in collaboration with colleagues in the United States, have developed an artificial neural network modeled after the human brain.
By analyzing data from over 240,000 ambulatory electrocardiograms (ECGs), the AI algorithm was able to identify patients at high risk of experiencing a life-threatening arrhythmia capable of triggering cardiac arrest within two weeks—with an accuracy exceeding 70%.
Sudden cardiac death claims more than 5 million lives globally each year. Often, these fatal events occur without warning, affecting individuals with no prior diagnosis of heart disease.
This study highlights the potential of AI to significantly improve the early detection of dangerous arrhythmias, abnormal heart rhythms that can lead to sudden cardiac arrest, by identifying at-risk patients before symptoms appear.
Developing an AI That Mimics the Brain
As part of this study, a network of artificial neurons was developed by a team of engineers from the company Cardiologs (Philips group) in collaboration with the universities of Paris Cité and Harvard. What this algorithm does is imitate the functions of the human brain in order to improve the prevention of cardiac sudden death.
The researchers analyzed several million hours of heartbeats thanks to data from 240,000 ambulatory electrocardiograms collected in six countries (USA, France, UK, South Africa, India, and Czechia).
Thanks to artificial intelligence, the researchers were able to identify new weak signals that herald the risk of arrhythmia. They were particularly interested in the time needed to electrically stimulate and relax the heart ventricles during a complete cycle of cardiac contraction and relaxation.
New Predictive Signals Identified
"By analyzing their electrical signal for 24 hours, we realized that we could identify the subjects susceptible of developing a serious heart arrhythmia within the next two weeks. If left untreated, this type of arrhythmia can progress towards a fatal cardiac arrest," explains Dr. Laurent Fiorina, first author of the study, researcher at the Paris Cardiovascular Research Centre (PARCC) (Inserm/Paris Cité University)," cardiologist at Cardiovascular Institute Paris-Sud (ICPS) (Ramsay, Massy), and medical director in charge of artificial intelligence at Philips.
While the artificial neural network is still in the evaluation phase, it showed itself in this study to be capable of detecting at-risk patients in 70% of cases, and no-risk patients in 99.9% of cases.
In the future, this algorithm could be used to monitor at-risk patients in hospitals. If its performance is refined, it could also be used in devices such as ambulatory Holters that measure blood pressure to reveal hypertension risks. It could even be used in smartwatches.
A Paradigm Shift in Cardiac Risk Prediction
"What we're proposing here is a paradigm change in the prevention of sudden death, "comments Eloi Marijon, Inserm research director at PARCC (Inserm/Paris Cité University), professor of cardiology at Paris Cité University and head of the cardiology department at Georges Pompidou European Hospital AP-HP.
"Until now we'd been trying to identify patients at risk over the medium and long term, but were incapable of predicting what could happen in the minutes, hours, or days that precede a cardiac arrest. Now, thanks to artificial intelligence, we can predict these events in the very short term and potentially take action before it's too late."
The researchers now wish to conduct prospective clinical studies to test the efficacy of this model under real-world conditions.
"It's essential for this technology to be evaluated in clinical trials before being used in medical practice," insists Dr. Fiorina. "But what we've already shown is that AI has the potential to radically transform the prevention of serious arrhythmias."
Reference: "Near-term prediction of sustained ventricular arrhythmias applying artificial intelligence to single-lead ambulatory electrocardiogram" by Laurent Fiorina, Tanner Carbonati, Kumar Narayanan, Jia Li, Christine Henry, Jagmeet P Singh and Eloi Marijon, 30 March 2025, European Heart Journal.
DOI: 10.1093/eurheartj/ehaf073
News
Brazilian Tree Compounds Fight COVID-19 on Multiple Fronts
Scientists found compounds in a Brazilian tree that hit SARS-CoV-2 on multiple fronts, revealing a promising new lead in the search for COVID-19 treatments. Researchers have found that galloylquinic acids extracted from the leaves [...]
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
